Dr. T. Narender Kumar

About Doctor DR. T. NARENDER KUMAR

• Dr. T. Narender Kumar is a Medical & Hemato Oncologist and BMT Physician and he has fellowship in Bone marrow transplant unit at CITY OF HOPE national medical center, Los Angeles, California 1 Nov 2013 - 28 Feb 2014 Los Angeles California, USA
• He is working as a
   Consultant in Medical & Hemato Oncologist and BMT Physician at KIMS Hospital,Hyderabad
• His specialization includes Medical & Hemato Oncologist and BMT Physician
• He got awarded 2nd Prize for Adult Acute Promyelocytic Leukemia – Retrospective Analysis. Presented as ORAL presentation at ISMPO VIZAG Meet 2012 in February 2012 Thota Narender Kumar, Gundeti Sada Shivudu, Coca Pragnya, Linga Vijay Gandhi, Digumarti Raghunadharao. Department of Medical Oncology, Nizam’s Institute of medical sciences, Punjagutta, Hyderabad, India.
• He judged as one of the best poster from India for ASCO, Chicago – USA, June 2011in Imatinib Mesylate (IM) As First Line Therapy In Patients With Chronic Myeloid Leukemia (CML) In Accelerated Phase (AP) And Blast Phase (BC): A Retrospective Analysis Narender Kumar Thota, S Gundeti, Pragnya Coca, Vijay Gandhi. L, Jayanthi Sri rambhatla, Radhika P, Raghunadharao Digumarti, Srinivas B͙* Dept. of Medical Oncology and *Pathology, Nizam’s Institute of Medical Sciences, Hyderabad, India

• He attended CPR – BLS / ACLS (Workshop) American heart association March 2003
• He attended ACLS workshop At Yashoda Superspeciality hospital Dec 2008
• He attended Young Medical Oncologists Meet MOFA, Hyderabad 10-11th June, 2008
• He attended Advancement in Renal Cell Carcinoma Mumbai, India 31st July – 1st Aug. 2010
• He attended Statistics for Health Researchers ( Online course) University of Oxford, London, U.K. 17 May - 23 July 2010
• He done conference on 42nd Annual Congress, SIOP at Boston, USA International society of pediatric oncology, Boston, USA 21 – 24, Oct, 2010
• He done Annual Conference of ASCO at Chicago, USA American Society of Clinical Oncology, USA June 3 – 7, 2011
• He done conference on Lymphomas and leukemias 2012, Mumbai, India 6-8 Jan, 2012
• He done conference on ISMPO Meet 2012 Vishakhapatnam, Andhra Pradesh , India February 2012
• He done conference on Global oncology summit (March 2013) Hyderabad, India 28-31 March, 2013
• He done conference on 2nd ISHBT EHA tutorial on myeloid malignancies and multiple myeloma Mumbai, India 29th to 31st January 2016.
• He published Plasma Cell Leukaemia Masquerading As Hairy Cell Leukaemia- A Case Report
• He Published online 22 January 2013. Indian Journal of Haematology and Blood Transfusion (Indian J Hematol Blood Transfusion DOI 10.1007/s12288-013-0228-5)
• He published Thota Narender Kumar, Kalpathi Krishnamani, Linga Vijay Gandhi, Gundeti Sadashivudu, Digumarti Raghunadharao.
• He published Imatinib Mesylate (IM) As First Line Therapy In Patients With Chronic Myeloid Leukemia (CML) In Accelerated Phase (AP) And Blast Phase (BC): A Retrospective Analysis
• He published Indian J Cancer 2014; 51:5-9.
• He published Narender Kumar Thota, S Gundeti, Pragnya Coca, Vijay Gandhi. L, Jayanthi Sri rambhatla, RadhikaP, Raghunadharao, Srinivas B͙* Dept. of Medical Oncology and *Pathology, Nizam’s Institute of Medical Sciences, Hyderabad, India
• He published T – CLL/T – PLL: Experience with single agent Bendamustine Case report - Indian Journal of Cancer. Published on April – June 2015.
• He published Narender Kumar Thota*, Sadashivudu Gundeti*, Pragnya coca, Vijay Gandhi Linga*, bhTara Roshni Paul# Raghunadharao Digumarti*
• He published *Departments of Medical Oncology, #Department of Pathology*, Nizam’s Institute of Medical Sciences, Hyderabad, India.
• He published Therapy Related Acute Promyelocytic Leukemia Following Etoposide Based Chemotherapy In Non–Seminomatous Germ Cell Tumor.
• He Published - J Postgrad Med 2014; 60:84-5. - Case snippet
• He published Narender Kumar Thota*, Vijay Gandhi Linga*, Krishna mani*, Sadashivudu Gundeti*, Raghunadharao Digumarti* *Departments of Medical Oncology, #Department of Pathology*, Nizam’s Institute of Medical Sciences, Hyderabad, India
• He Published - South Asian journal of cancer (July- September 2013) as letters to editor, Kalpathi Krishnamani, Thota Narender Kumar, Linga Vijay Gandhi, Gundeti Sadashivudu, Digumarti Raghunadharao, Ashwani Tandon1.
• He published Diagnostic Dilemma Of Cardiac Synovial Sarcoma - Primary Or Secondary:- Published - Journal of Indian College of Cardiology (13 May 2013) Kalpathi Krishnamani, Linga Vijay Gandhi, Thota Narender Kumar 1, Gundeti Sadashivudu, Digumarti Raghunadharao, Rama Kumari N2.
• He published Primary Ewing’s Sarcoma of the Cranium- Case Series and Review of Literature:-Journal of Cancer Research and Therapeutics, 2014; 10:377-80.
• He published Kalpathi Krishnamani *, Thota Narender Kumar*, Linga Vijay Gandhi*, Digumarti Raghunadharao*, Gundeti Sadashivudu*, Uppin Megha #, C. Sundaram #.
• He published *Departments of Medical Oncology, #Department of Pathology*, Nizam’s Institute of Medical Sciences, Hyderabad, India
• He published ortezomib in Newly diagnosed patients with Multiple Myeloma: a retrospective analysis from a tertiary care centre in India"
• He published Accepted for publication in Indian Journal of Cancer. The ref no: IJC_186_12
• He published Coca Pragnya, Thota Narender Kumar, Gundeti Sadashivudu, Linga Vijay Gandhi, Srinivas Lakshmi, Digumarti Raghunadharao, Department of Medical Oncology, Nizam’s Institute of Medical Sciences, Hyderabad.
• He done abstracts The Frequency Of Thiopurine Methyl Transferase Polymorphisms In Children’s With Acute Lymphoblastic Leukemi,Granted a Travelling Grant for SIOP 2010, Boston, USA
• He done abstracts Abstract number: 681. Published in the abstract book of the SIOP.Narender Kumar Thota*, Vijay Gandhi Linga*, Pragnya coca*, Sadashivudu Gundeti*, Tara Roshni Paul# Raghunadharao Digumarti*,CHOP chemotherapy plus rituximab compared with CHOP alone in patients with diffuse large B-cell lymphoma, from Indian subcontinent
• He Published as abstract in J Clin Oncol 30, 2012 (suppl; abstr e18545),Vijay Gandhi Linga, Raghunadharao Digumarti, Rahul Narayan Maddi, Vamshi Krishna Reddy Goteke, Sadashivudu Gundeti, Narender Kumar Thota, Pragnya Coca; Department of Medical Oncology, Hyderabad, India; Nizam's Institute of Medical Sciences, Hyderabad, India
• He Published as abstract in Weight loss of more than ten per cent and radiographic findings are the most important predictive factor for suspecting tuberculosis in patients with multiple myeloma post autologous transplant
• He Published as abstract in G Linga, S Gundeti, Narender kumar Thota, P Coca, R Digumarti BONE MARROW TRANSPLANTATION 47, S337-S337
• He Published as abstract in An anthropometric study in children with chronic myeloid leukemia on imatinibVKR Goteke, RN Maddi, NK Thota, P Coca, B Nagalla, VG Linga, S Gundeti,,JOURNAL OF CLINICAL ONCOLOGY 30 (15)
• He Published as abstract in ROSAI-DORFMAN'S DISEASE (RDD) PRESENTING AS AN ISOLATED INTRASPINAL MASS: A CASE REPORT AND REVIEW OF LITERATURE FROM THE INDIAN SUBCONTINENT
• He Published as abstract in Coca, Pragnya, Narender Kumar Thota, Vijay Gandhi Linga, Sadashivudu Gundeti, Raghunadharao Digumarti, and S. V. N. Anuradha,PEDIATRIC BLOOD & CANCER 60 (9), E74-E74
• He presented Adult Acute Promyelocytic Leukemia – Retrospective Analysis- awarded 2nd prize.
• He Presented as ORAL presentation at ISMPO VIZAG Meet 2012 in February 2012
• He presented Thota Narender Kumar, Gundeti sada shivudu, Coca Pragnya, Linga Vijay Gandhi, Digumarti Raghunadharao. Department of Medical Oncology, Nizam’s Institute of medical sciences, Punjagutta, Hyderabad, India.
• He presented “ Effects Of Imatinib Therapy On Serum Calcium, Phosphate And Magnesium Levels And Correlation With Musculo-Skeletal Symptoms In Chronic Myeloid Leukemia Patients”
• He Presented at the ISMPO VIZAG Meet 2012 in February 2012
• He presented Coca Pragnya, Thota Narender Kumar, Gundeti Sadashivudu, Linga Vijay Gandhi, Srinivas Lakshmi, Digumarti Raghunadharao, Department of Medical Oncology, Nizam’s Institute of Medical Sciences, Hyderabad
• He presented Imatinib drug level monitoring in chronic phase chronic myeloid leukemia patients after 6 months of therapy. Radhika P, Narender Kumar Thota, S Gundeti, Pragnya Coca, Vijay Gandhi. L, Jayanthi Sri rambhatla,, Raghunadharao Digumarti, Srinivas B͙* Dept. of Medical Oncology and *Pathology, Nizam’sInstitute of Medical Sciences, Hyderabad, India
• He presented Outcome of Patients on First Line Pemetrexed Doublet in Advanced Stage Adenocarcinoma of Lung Rahul Narayan Maddi, Vamshi Krishna Reddy G, Pragnya Coca, Narender Kumar Thota, Radhika P, Jayanthi S, Vijay Gandhi Linga, Sadashivudu G, Lakshmi S, Raghunadharao Digumarti
• He presented Imatinib Mesylate (IM) As First Line Therapy In Patients With Chronic Myeloid Leukemia (CML) In Accelerated Phase (AP) And Blast Phase (BC): A Retrospective Analysis
• He Presented as poster at ASCO, Chicago – USA, June 2011
• He Selected as one of the 4 best papers from India for ASCO, USA, June 2011
• He presented Narender Kumar Thota, S Gundeti, Pragnya Coca, Vijay Gandhi. L, Jayanthi Sri rambhatla, Radhika P, Raghunadharao Digumarti, Srinivas B͙* Dept. of Medical Oncology and *Pathology, Nizam’s Institute of Medical Sciences, Hyderabad, India
• He presented An anthropometric study in children with chronic myeloid leukemia on imatinib.
• He Presented as poster at ASCO, Chicago, USA. June 1-5, 2012
• He presented Vamshi Krishna Reddy Goteke, Rahul Narayan Maddi, Narender Kumar Thota, Pragnya Coca, Balakrishna Nagalla, Vijay Gandhi Linga, Sadashivudu Gundeti, Raghunadharao Digumarti; Nizam's Institute of Medical Sciences, Hyderabad, India; Department of Medical Oncology, Hyderabad, India; National Institute of Nutrition, Hyderabad, India
• He presented Rosai-Dorfman’s Disease Presenting As An Isolated Intraspinal Mass: A Case Report And Review Of Literature From The Indian Subcontinent
• He Selected as poster at 28th Annual Meeting of the Histiocyte Society - London, UK October 8&9 2012 Pragnya Coca, Narender Kumar Thota, Vijay Gandhi Linga, Sadashivudu Gundeti, Raghunadharao Digumarti, SVN Anuradha
• He presented Initial Experience of Autologous Peripheral Blood Stem Cell Transplant – A University Hospital Experience
• He Presented as poster at 17 Asia- pacific bone marrow transplant, Hyderabad Oct 26-28, 2012
• He presented Primary cardiac synovial sarcoma presenting as multiple subcutaneous swellings – case report Presented at the Indian Cancer Congress- February 2011, Bhubaneshwar.
• He presented Narender Kumar Thota, Pragnya Coca, Jayanthi Srirambhatla, Radhika.P, VamshikrishnaG, Rahulnarayan.M, Vijay Gandhi Linga, SadashivuluGundeti, LakshmiM, RaghunadharaoDigumarti, DEPARTMENT OF MEDICAL ONCOLOGY, Nizam’sInstitute of Medical Sciences, Hyderabad, India
• He presented Retrospective Analysis Of Prognostic Factors And Outcomes In Small Cell Lung Cancer Presented as poster at vizag – ISMPO -2012
• He presented Thota Narender Kumar, Gundeti Sada shivudu, Coca Pragnya, Linga Vijay Gandhi, Digumarti Raghunadharao, Department of medical oncology, Nizam’s institute of Medical sciences, Hyderabad
• He presented Pediatric Acute Promyelocytic Leukemia – Retrospective Analysis Presented as poster at Mumbai LYMPHOMAS AND LEUKEMIAS 2012, 6-8 January, 2012 Thota Narender Kumar, Linga vijay Gandhi, Coca pragnya, Gundeti sada shivudu, Lakshmi srinivas M, Digumarti Raghunadharao
• He presented Department of Medical Oncology, Nizam’s Institute of medical sciences, Punjagutta, Hyderabad, India
• He presented Plasma Cell Leukaemia Masquerading As Hairy Cell Leukemia – Case Report
• He Presented as posters at Mumbai LYMPHOMAS AND LEUKEMIAS 2012, 6-8 January, 2012
• He presented Thota Narender Kumar, Linga Vijay Gandhi, Coca Pragnya, Gundeti sada shivudu, Lakshmi srinivas M, Digumarti Raghunadharao
• He presented Department of Medical Oncology, Nizam’s Institute of medical sciences, Punjagutta, Hyderabad, India
• He presented Imatinib Mesylate As Front Line Agent In Pediatric Chronic Myeloid Leukemia Accelerated Phase and Blast crisis Patients – Retrospective Analysis
• He Presented as posters at Mumbai LYMPHOMAS AND LEUKEMIAS 2012, 6-8 January, 2012 Thota Narender Kumar, Coca Pragnya, Maddi Rahul Narayan, GVK Reddy, Linga Vijay Gandhi, Gundeti Sadashivudu, Roshni Paul#, M.Lakshmi Srinivas, Digumarti Raghunadharao Department of Medical Oncology, #Depart of pathology, Nizam’s Institute of Medical Sciences, Hyderabad, India.
• He got awarded 2nd Prize for Adult Acute Promyelocytic Leukemia – Retrospective Analysis. Presented as ORAL presentation at ISMPO VIZAG Meet 2012 in February 2012 Thota Narender Kumar, Gundeti Sada Shivudu, Coca Pragnya, Linga Vijay Gandhi, Digumarti Raghunadharao. Department of Medical Oncology, Nizam’s Institute of medical sciences, Punjagutta, Hyderabad, India.
• He judged as one of the best poster from India for ASCO, Chicago – USA, June 2011in Imatinib Mesylate (IM) As First Line Therapy In Patients With Chronic Myeloid Leukemia (CML) In Accelerated Phase (AP) And Blast Phase (BC): A Retrospective Analysis Narender Kumar Thota, S Gundeti, Pragnya Coca, Vijay Gandhi. L, Jayanthi Sri rambhatla, Radhika P, Raghunadharao Digumarti, Srinivas B͙* Dept. of Medical Oncology and *Pathology, Nizam’s Institute of Medical Sciences, Hyderabad, India
• He done training in Management of various solid and haematological malignancies in adult and pediatric patients. Well-versed with various frontline protocols like
• He done training in BFM 90, MCP 841 & Paediatric A.L.L. protocol
• He done training in BFM 87 for paediatric A.M.L. and “7+3”/DAT protocols for adult A.M.L.
• He done training in ABVD, COPP, BFM 86, hyper CVAD, CODOX-M/IVAC, FLAG, FLAG-Ida, DHAP, ASHAP, ESHAP, R-ICE protocols for relapsed leukemias and lymphomas
• He done training in High dose Ifosfamide / Cyclophosphamide and High dose Methotrexate based regimens for sarcomas (soft tissue and bone).
• He done training in BEAM, BuCy, HD Melphalan for stem cell transplants
• He done training in T for breast cancer; Platinum-based regimens for lung, testicular and ovarian cancers; P+F, TIP for head and neck cancers; FOLFOX, FOLFIRI, CAPOX, CAPIRI etc. for colorectal cancers; concurrent chemo-radiation protocols for head and neck, oesophageal and anal canal/rectal cancersàConventional protocols like FAC, CMF, AT, AC
• He has Experience with newer molecules like Rituximab, Cetuximab, Herceptin, Bevacizumab, Velcade, Gefitinib etc.
• He done training in Maintenance of chemo ports, central catheters, PICCs, Omaya reservoirs etc.
• He done training in Allogenic transplant - Siblings, matched unrelated, haploidentical and cord blood transplant High dose chemotherapy/ Auto BMT and management of associated toxicities
• He done training in Lumbar punctures and intrathecal administration of chemotherapeutic agents
• He done training in Ascitic fluid and pleural fluid tappings
• He done training in FNAC from breast masses, lymph nodes, lung masses, subcutaneous nodules, skin lesions etc
• He has been faculty in Stem cell conference – KIMS
• He done Guest lecture on BMT – chalamada ananda rao karimnagar – 30.08.15
• He has been faculty in Update on current management of chronic leukemias – 5-6.09.15 KIMS cancer summit , Hyderabad
• He has been faculty in Resurrecting PARP inhibitors in Advanced breast cancer – 20.02.16 , Update on ABC 3 hyderabad, Taj Vivanta
• He has Travel grant to attend SIOP conference. SIOP 2010 BOSTON USA
• He has Fellowship in Bone marrow transplant unit at CITY OF HOPE national medical center, Los Angeles, California 1 Nov 2013 - 28 Feb 2014 Los Angeles California, USA
• He has Travel Grant and ESMO Preceptorship on Colorectal Cancer 27-28 March 2015 Singapore